Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Ahmet Aydin

Concepts (170)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
7
2022
165
2.990
 Why?
Penile Neoplasms
6
2021
44
2.950
 Why?
Carcinoma, Squamous Cell
5
2021
332
1.890
 Why?
Carcinoma, Transitional Cell
3
2022
54
1.510
 Why?
Prostatic Neoplasms
3
2020
398
1.480
 Why?
Kidney Neoplasms
5
2021
182
1.470
 Why?
Lymphocytes, Tumor-Infiltrating
3
2021
78
1.400
 Why?
Carcinoma, Renal Cell
4
2021
111
0.980
 Why?
Immunotherapy
6
2021
244
0.850
 Why?
Pheochromocytoma
1
2023
35
0.850
 Why?
Adrenal Gland Neoplasms
1
2023
49
0.840
 Why?
Biliary Tract Neoplasms
1
2022
6
0.790
 Why?
Lymphocytes
1
2022
153
0.740
 Why?
Urothelium
1
2021
19
0.720
 Why?
BCG Vaccine
2
2020
16
0.700
 Why?
Neoadjuvant Therapy
5
2022
125
0.680
 Why?
Indocyanine Green
1
2020
33
0.680
 Why?
Cancer Vaccines
1
2021
78
0.670
 Why?
Ubiquitin Thiolesterase
2
2021
19
0.670
 Why?
CD8-Positive T-Lymphocytes
1
2021
132
0.660
 Why?
Adjuvants, Immunologic
1
2020
52
0.650
 Why?
Male
27
2023
26761
0.630
 Why?
Anesthesia, Local
1
2019
17
0.630
 Why?
Patient Readmission
1
2021
246
0.630
 Why?
Edetic Acid
1
2019
14
0.630
 Why?
Tumor Suppressor Proteins
2
2021
130
0.630
 Why?
Testicular Neoplasms
4
2021
46
0.620
 Why?
Ureteral Neoplasms
1
2019
11
0.620
 Why?
Immunotherapy, Adoptive
1
2021
166
0.620
 Why?
Prostate-Specific Antigen
1
2019
44
0.610
 Why?
Papillomavirus Infections
1
2021
173
0.610
 Why?
Oligopeptides
1
2019
92
0.590
 Why?
Humans
35
2023
52483
0.570
 Why?
Retrospective Studies
12
2023
6607
0.550
 Why?
Neoplasm Recurrence, Local
4
2021
649
0.550
 Why?
Cystectomy
3
2022
51
0.540
 Why?
Silver Nitrate
1
2016
2
0.530
 Why?
Arteriovenous Fistula
1
2016
28
0.510
 Why?
Silver
1
2016
52
0.510
 Why?
Metal Nanoparticles
1
2016
86
0.490
 Why?
Neoplasms, Germ Cell and Embryonal
3
2021
20
0.460
 Why?
Middle Aged
14
2023
13028
0.460
 Why?
Aged
13
2023
10121
0.450
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2022
1031
0.440
 Why?
Lymphatic Metastasis
4
2021
220
0.410
 Why?
Neoplasm Grading
4
2020
126
0.390
 Why?
Female
17
2023
28171
0.380
 Why?
Prognosis
4
2022
2099
0.380
 Why?
Neoplasm Invasiveness
3
2022
278
0.370
 Why?
Tumor Microenvironment
3
2021
256
0.340
 Why?
Postoperative Complications
4
2021
1068
0.310
 Why?
Lymph Nodes
2
2021
258
0.300
 Why?
Treatment Outcome
8
2023
5422
0.300
 Why?
Prospective Studies
2
2022
2481
0.240
 Why?
Upper Gastrointestinal Tract
1
2004
5
0.230
 Why?
Gastrointestinal Stromal Tumors
1
2004
19
0.230
 Why?
Neoplasm Metastasis
3
2021
243
0.230
 Why?
Adult
9
2023
14161
0.230
 Why?
Endosonography
1
2004
98
0.220
 Why?
Quality of Life
2
2020
879
0.220
 Why?
Adrenalectomy
1
2023
31
0.220
 Why?
Adrenal Glands
1
2023
39
0.220
 Why?
Aged, 80 and over
3
2021
3392
0.210
 Why?
Spondylolisthesis
1
2023
9
0.200
 Why?
Neoplasm Staging
3
2021
772
0.200
 Why?
Deoxycytidine
1
2022
29
0.200
 Why?
Retroperitoneal Space
2
2021
26
0.190
 Why?
Spinal Fusion
1
2023
72
0.190
 Why?
Muscles
1
2022
107
0.190
 Why?
Cohort Studies
3
2021
1542
0.190
 Why?
Mycobacterium bovis
1
2021
11
0.180
 Why?
Antigens, Differentiation, Myelomonocytic
1
2021
39
0.180
 Why?
Neutrophils
1
2022
147
0.180
 Why?
Lymph Node Excision
2
2021
133
0.180
 Why?
Aftercare
1
2021
76
0.180
 Why?
Teratoma
1
2021
24
0.180
 Why?
T-Lymphocytes
2
2020
340
0.180
 Why?
Interleukin-2
1
2021
69
0.180
 Why?
Reference Standards
1
2020
54
0.170
 Why?
Tomography, Emission-Computed
1
2020
53
0.170
 Why?
Fluorouracil
1
2020
59
0.170
 Why?
Lymphocyte Activation
1
2021
172
0.170
 Why?
Cisplatin
1
2022
285
0.170
 Why?
Recurrence
2
2019
672
0.170
 Why?
Carcinoma in Situ
1
2020
72
0.170
 Why?
Antigens, CD
1
2021
218
0.160
 Why?
Sentinel Lymph Node Biopsy
1
2020
120
0.160
 Why?
Cells, Cultured
2
2021
1567
0.160
 Why?
Survival Rate
2
2019
945
0.160
 Why?
Gallium Isotopes
1
2019
2
0.160
 Why?
Gallium Radioisotopes
1
2019
10
0.160
 Why?
Kidney Pelvis
1
2019
16
0.160
 Why?
Patient Discharge
1
2021
330
0.150
 Why?
Disease-Free Survival
1
2020
460
0.150
 Why?
Genomics
1
2020
268
0.150
 Why?
Feasibility Studies
1
2020
406
0.150
 Why?
Papillomavirus Vaccines
1
2019
70
0.150
 Why?
Urologic Neoplasms
1
2018
12
0.150
 Why?
Ureteral Obstruction
1
2019
62
0.150
 Why?
Inflammation
1
2022
641
0.140
 Why?
Carcinoma, Papillary
1
2018
51
0.140
 Why?
Spine
1
2018
89
0.140
 Why?
Antineoplastic Agents
3
2020
1222
0.140
 Why?
Genetic Predisposition to Disease
1
2020
528
0.140
 Why?
Biopsy
1
2019
605
0.130
 Why?
Cell Proliferation
1
2021
1023
0.130
 Why?
Maternal-Fetal Exchange
1
2016
49
0.130
 Why?
Renal Artery
1
2016
32
0.130
 Why?
Tissue Distribution
1
2016
171
0.130
 Why?
Gene Expression Regulation, Neoplastic
1
2020
857
0.130
 Why?
Diaphyses
1
2016
4
0.130
 Why?
Femur Neck
1
2016
7
0.130
 Why?
Fracture Fixation, Intramedullary
1
2016
9
0.130
 Why?
Milk
1
2016
81
0.130
 Why?
Nephrectomy
1
2016
82
0.130
 Why?
Hypericum
1
2015
14
0.120
 Why?
Time Factors
2
2020
2968
0.120
 Why?
Catechin
1
2015
16
0.120
 Why?
Models, Anatomic
1
2016
41
0.120
 Why?
Polyphenols
1
2015
38
0.120
 Why?
Weight Gain
1
2016
240
0.120
 Why?
Urinary Tract Infections
1
2015
57
0.110
 Why?
Laparoscopy
1
2016
180
0.110
 Why?
Plant Extracts
1
2015
194
0.100
 Why?
Kidney Transplantation
1
2015
192
0.100
 Why?
Kidney Failure, Chronic
1
2015
210
0.100
 Why?
Rats, Sprague-Dawley
1
2016
1563
0.100
 Why?
Follow-Up Studies
4
2020
2279
0.100
 Why?
Oxidative Stress
1
2016
807
0.090
 Why?
Risk Factors
1
2019
3889
0.090
 Why?
Chemotherapy, Adjuvant
2
2020
124
0.080
 Why?
Kaplan-Meier Estimate
2
2021
483
0.080
 Why?
Pregnancy
1
2016
2680
0.080
 Why?
Brain
1
2016
1323
0.070
 Why?
Survival Analysis
2
2021
673
0.070
 Why?
Reproducibility of Results
2
2016
1229
0.070
 Why?
Animals
2
2020
13505
0.060
 Why?
Lumbar Vertebrae
1
2023
104
0.050
 Why?
Diagnosis, Differential
1
2004
1046
0.040
 Why?
Immune System
1
2021
42
0.040
 Why?
T-Lymphocyte Subsets
1
2021
41
0.040
 Why?
Administration, Topical
1
2020
61
0.040
 Why?
Forkhead Transcription Factors
1
2021
116
0.040
 Why?
Urinary Bladder
1
2020
101
0.040
 Why?
Pain
1
2023
362
0.040
 Why?
Patient Selection
1
2020
259
0.040
 Why?
Treatment Failure
1
2019
122
0.040
 Why?
Macrophages
1
2021
379
0.040
 Why?
Socioeconomic Factors
1
2020
610
0.040
 Why?
Health Facilities
1
2017
40
0.040
 Why?
Oncolytic Virotherapy
1
2017
21
0.030
 Why?
Combined Modality Therapy
1
2018
639
0.030
 Why?
Cadaver
1
2016
96
0.030
 Why?
Adolescent
2
2019
6739
0.030
 Why?
Turkey
1
2015
16
0.030
 Why?
Mutation
1
2021
1347
0.030
 Why?
Leukocytes, Mononuclear
1
2015
123
0.030
 Why?
Clinical Trials as Topic
1
2017
467
0.030
 Why?
Graft Survival
1
2015
160
0.030
 Why?
Child
2
2019
7248
0.030
 Why?
Registries
1
2017
581
0.030
 Why?
Cytokines
1
2017
623
0.030
 Why?
Cell Survival
1
2015
612
0.030
 Why?
Antibodies, Monoclonal
1
2017
481
0.030
 Why?
Cell Line
1
2015
1030
0.030
 Why?
Tomography, X-Ray Computed
1
2016
1165
0.020
 Why?
Mice
1
2020
5949
0.020
 Why?
Child, Preschool
1
2019
4076
0.020
 Why?
Young Adult
1
2018
4329
0.020
 Why?
United States
1
2017
5192
0.020
 Why?
Aydin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (170) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department